China Industries
Adora Flora City, China’s second domestically-built large cruise ship, undocks in Shanghai on March 20. The vessel is now structurally complete and ready for final commissioning. It will be delivered by the end of 2026 and will operate international routes from Guangzhou Nansha International Cruise Home Port. DING TING/XINHUA A little more than two years…
A technician checks humanoid robots at a technology center in Zigong, Sichuan province. HE HAIYANG/FOR CHINA DAILY BEIJING — The 2026 China Unicorn Companies Development Report was launched recently in Beijing, underscoring China’s position as a major hub for high-growth enterprises. The report said China is home to 416 unicorn companies, accounting for nearly 30…
The market size of core industries for smart economy, or core industries powered by artificial intelligence, is projected to reach 12.6 trillion yuan ($1.83 trillion) by 2030, accounting for 25.1 percent of the country’s digital economy revenue, according to a forecast released by a research institute affiliated with the Ministry of Industry and Information Technology.…
China has approved a domestically developed radioactive imaging drug to help detect whether lung cancer has spread to lymph nodes, marking a step forward for the country’s nuclear medicine industry. The National Medical Products Administration said in a statement online on April 2 it approved technetium [99mTc] pexidotide injection and its preparation kit through a…
Gut microbiota research is opening up fresh opportunities for innovative drug discovery and health product innovation, experts said recently in Beijing, as China steps up efforts to foster biopharmaceutical innovation. Growing evidence shows that gut microbes are closely linked to a broad range of diseases, creating new room for pharmaceutical innovation and industrial upgrading, said…
China’s fast-growing market for GLP-1 weight-loss drugs is bracing for a major shake-up as the core compound patent for semaglutide was expiring in March, opening the door for multiple domestic pharmaceutical companies to launch generic versions and compete for a market worth tens of billions of yuan. Prices for several leading obesity drugs have already…
Researchers work at a lab of a biopharmaceutical company in Wuxi, Jiangsu province. QI LIGUANG/FOR CHINA DAILY China’s biopharmaceutical sector is off to a strong start in 2026, with record cross-border out-licensing activity and a growing pipeline of homegrown innovative drugs signaling the country’s rising role in the global biotech landscape. Data from the National…
Business and government delegations from 18 countries gathered in Qingdao, Shandong province, for a commodity procurement matchmaking event held on Monday and Tuesday. Organizers said the event aims to help high-quality and distinctive products from other member countries of the Shanghai Cooperation Organization better access China’s vast domestic market, while building a trade and economic…
Exhibitors from green food and consumer goods sectors participate in matchmaking activities during a CIIE-related event in Hefei, Anhui province, on Tuesday. CHINA DAILY What began as a showcase for overseas brands entering China is increasingly turning into a launchpad for long-term investment, as multinational firms deepen their presence through a China International Import Expo…
Sorona’s booth is seen during a textile expo in Shanghai. CHINA DAILY Rising oil prices are rippling through global textile supply chains, pushing up the cost of petroleum-based fibers and prompting manufacturers to accelerate a shift toward bio-based alternatives. Geopolitical tensions in the Middle East have fueled a rally in crude oil, lifting the prices…